Approved by the House Energy and Commerce Health Subcommittee on 11 March, H.R. 5279 still lacks any concrete provisions regarding federal preemption of state and local requirements, though bill author and full committee chair Frank Pallone, D-NJ, remains committed to discussions on the subject. He recognized preemption as “a major issue that I know we have to deal with.”
Small business impacts, the safety of cosmetic products aimed at women of color, and per- and polyfluoroalkyl substances (PFAS) were key concerns voiced by House Energy and Commerce Health Subcommittee members during an 11 March markup of the Cosmetic Safety Enhancement Act.
In comparison, industry’s top priority, preemption,